Seventeen-years overview of breast cancer inside and outside screening in Denmark

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Autier P, Boniol M, La Vecchia C, Vatten L, Gavin A, Hery C, . Disparities in breast cancer mortality trends between 30 European countries: Retrospective trend analysis of WHO mortality database. BMJ 2010;341:c3620.
   PubMed Web of Science ®Google Scholar
• Euler-Chelpin M. Breast cancer incidence and use of hormone therapy in Denmark 1978–2007. Cancer Causes Control 2011;22:181–7.
   PubMed Web of Science ®Google Scholar
• Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, . The decrease in breast- cancer incidence in 2003 in the United States. N Engl J Med 2007;356:1670–4.
   PubMed Web of Science ®Google Scholar
• Bordas P, Jonsson H, Nystrom L, Lenner P. Survival from invasive breast cancer among interval cases in the mammography screening programmes of northern Sweden. Breast 2007;16:47–54.
   PubMed Web of Science ®Google Scholar
• Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, editors. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg: Office for Official Publications of the European Communities; 2006.
   Google Scholar
• Svendsen AL, Olsen AH, Euler-Chelpin M, Lynge E. Breast cancer incidence after the introduction of mammography screening: What should be expected? Cancer 2006;106: 1883–90.
   PubMed Web of Science ®Google Scholar
• Bennett RL, Sellars SJ, Moss SM. Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland. Br J Cancer 2011;104:571–7.
   PubMed Web of Science ®Google Scholar
• Bordas P, Jonsson H, Nystrom L, Lenner P. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden. J Med Screen 2009;16:39–45.
   PubMed Web of Science ®Google Scholar
• Tornberg S, Kemetli L, Ascunce N, Hofvind S, Anttila A, Seradour B, . A pooled analysis of interval cancer rates in six European countries. Eur J Cancer Prev 2010;19:87–93.
   PubMed Web of Science ®Google Scholar
• Bucchi L, Ravaioli A, Foca F, Colamartini A, Falcini F, Naldoni C. Incidence of interval breast cancers after 650,000 negative mammographies in 13 Italian health districts. J Med Screen 2008;15:30–5.
   PubMed Web of Science ®Google Scholar
• Utzon-Frank N, Vejborg I, Euler-Chelpin M, Lynge E. Balancing sensitivity and specificity: Sixteen year’s of experience from the mammography screening programme in Copenhagen, Denmark. Cancer Epidemiol 2011;35:393–8.
   PubMed Web of Science ®Google Scholar
• Jensen A, Olsen AH, Euler-Chelpin M, Helle NS, Vejborg I, Lynge E. Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer 2005; 113:464–70.
   PubMed Web of Science ®Google Scholar
• Njor SH, Olsen AH, Bellstrom T, Dyreborg U, Bak M, Axelsson C, . Mammography screening in the county of Fyn. November 1993–December 1999. APMIS Suppl 2003; (110):1–33.
   Google Scholar
• Domingo L, Sala M, Servitja S, Corominas JM, Ferrer F, Martinez J, . Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain. Cancer Causes Control 2010;21:1155–64.
   PubMed Web of Science ®Google Scholar
• Hofvind S, Geller B, Skaane P. Mammographic features and histopathological findings of interval breast cancers. Acta Radiol 2008;49:975–81.
   PubMed Web of Science ®Google Scholar
• Vitak B, Olsen KE, Manson JC, Arnesson LG, Stal O. Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: A comparison of true interval and missed interval cancers. Eur Radiol 1999;9:460–9.
   PubMed Web of Science ®Google Scholar
• Zackrisson S, Andersson I, Manjer J, Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer 2004;108:754–60.
   PubMed Web of Science ®Google Scholar
• Euler-Chelpin M, Olsen AH, Njor S, Vejborg I, Schwartz W, Lynge E. Women’s patterns of participation in mammography screening in Denmark. Eur J Epidemiol 2006;21: 203–9.
   PubMed Web of Science ®Google Scholar
• Njor SH, Olsen AH, Schwartz W, Vejborg I, Lynge E. Predicting the risk of a false-positive test for women following a mammography screening programme. J Med Screen 2007;14: 94–7.
   PubMed Web of Science ®Google Scholar
• Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Verbeek AL, Hendriks JH, . Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 1999;81: 912–7.
   PubMed Web of Science ®Google Scholar
• Sarkeala T, Hakama M, Saarenmaa I, Hakulinen T, Forsman H, Anttila A. Episode sensitivity in association with process indicators in the Finnish breast cancer screening program. Int J Cancer 2006;118:174–9.
   PubMed Web of Science ®Google Scholar
• Hofvind S, Bjurstam N, Sorum R, Bjorndal H, Thoresen S, Skaane P. Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programme. J Med Screen 2006;13:192–6.
   PubMed Web of Science ®Google Scholar
• Lawrence G, O’Sullivan E, Kearins O, Tappenden N, Martin K, Wallis M. Screening histories of invasive breast cancers diagnosed 1989–2006 in the West Midlands, UK: variation with time and impact on 10-year survival. J Med Screen 2009;16:186–92.
   PubMed Web of Science ®Google Scholar
• Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: A population based study. Breast Cancer Res 2012;14:R10.
   PubMed Web of Science ®Google Scholar